Cryoplateable Hepatocytes
Closed Pre-Solicitation Posted
Not the latest version. See the latest special notice from .
- Solicitation number
- PANDHA-25-P-0000-018865-RFI
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency is conducting market research for the procurement of cryoplateable hepatocytes to support viral disease research at the Walter Reed Army Institute of Research (WRAIR) Viral Diseases Program. This Request for Information seeks prime contractors capable of providing specialized human and monkey hepatocytes that meet stringent viability and infectivity requirements, including 75% viability when thawed and the ability to support malaria liver-stage and flavivirus infections. The hepatocytes must be delivered in liquid nitrogen cryoshippers maintaining temperatures of -150°C or colder, with each lot undergoing in-house evaluation by WRAIR's Integrated Pathogen Therapeutics Department to assess plateability and infectivity. Vendors must submit capability statements limited to 5 pages via email to specified government contacts by 10:00 AM EST on July 14, 2025. This RFI is issued solely for information and planning purposes and does not constitute a solicitation, with responses not forming binding contracts.
No set-aside designation applies to this opportunity, making it open to all qualified contractors. The procurement will operate under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract structure with a five-year ordering period from December 15, 2025, to December 14, 2030. The government requires up to 250 vials per year of monkey hepatocytes and 100 vials per year of human hepatocytes, with quarterly shipments planned throughout the contract period. Specific donor requirements include a minimum of 100 vials from a single donor and hepatocytes from at least 5 different monkey donors. While no contract values or budget ranges are specified in this market research phase, the multi-year commitment and specialized nature of these biological products suggest a substantial procurement opportunity for qualified biotechnology manufacturers.
Notice text
This is a Request for Market Research purposes for the purchase and Delivery of human and monkey cryoplateable hepatocytes to Walter Reed Army Institute of Research (WRAIR), Viral Diseases Program (VDP).
This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. All information received in response to this RFI that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future RFP will not be entertained.
See Attached Request for Information and the Draft copy Material Essential Characteristics (MECs) for Cryoplateable Hepatocytes
Files
| File | Type | Posted |
|---|---|---|
| A02. Request for Information Cryoplateable Hepatocytes IDIQ.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Cryoplateable Hepatocytes IDIQ | Limited / Sole Source Justification | |
| Cryoplateable Hepatocytes | Special Notice | |
| This notice | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity